Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy-Reference-Cited by-同舟云学术

Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy

Published:2018-12 Issue:12 Volume:102 Page:2088-2095
ISSN:1534-6080
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Bowring Mary G.,Kucirka Lauren M.,Massie Allan B.,Ishaque Tanveen,Bae Sunjae,Shaffer Ashton A.,Garonzik Wang Jacqueline,Sulkowski Mark,Desai Niraj,Segev Dorry L.,Durand Christine M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference50 articles.

1. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS;Kidney Int,2004

2. Hepatitis C virus transmission in the hemodialysis community;Am J Kidney Dis,2001

3. Hepatitis C screening strategies in hemodialysis patients;Am J Kidney Dis,2001

4. Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis;J Viral Hepat,2007

5. Mortality in hepatitis C-positive patients treated with peritoneal dialysis;Perit Dial Int,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Center and Individual Willingness to Consider Heart and Lung Offers From Donors With Hepatitis C;Journal of Surgical Research;2024-10

2. Kidney Transplantation From Hepatitis C Virus–Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update;American Journal of Kidney Diseases;2023-10

3. Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease;Advances in Kidney Disease and Health;2023-07

4. Temporal changes in the utilization of kidneys from hepatitis C virus–infected donors in the United States;American Journal of Transplantation;2023-06

5. Kidney Transplantation in an Elderly Veteran Population With Hepatitis C Virus Nucleic Acid Test–Positive Donors Results in Improved Outcomes After Prophylactic Glecaprevir/Pibrentasvir Therapy;Transplantation Proceedings;2023-03